Baltic states

The Baltic states is a geopolitical term, typically used to group the three sovereign states in Northern Europe on the eastern coast of the Baltic Sea: Estonia, Latvia, and Lithuania.

The three countries do not form an official union, but engage in intergovernmental and parliamentary cooperation. The most important areas of cooperation between the three countries are foreign and security policy, defence, energy and transportation.

Contact us

Do you want to learn more about our services and previous projects? Give us a heads up and one of our experts will reach out to you.

Clas Lindbergson

FrostPharma Head of Business Development

Karin Torberger

FrostPharma Director Business Development
Baltics

Baltics in brief

All three countries are members of the European Union, and the Eurozone. They are classified as high-income economies by the World Bank and maintain high Human Development Index. Estonia, Latvia, and Lithuania are also members of the OECD.

Estonia adopted the euro in January 2011, Latvia in January 2014, and Lithuania in January 2015.

Services

Sales and Marketing

Entering the European market is not easy. Up to 51 countries with different healthcare systems. What is your strategy? Apart from the Big-5, what do you do with the other 28 countries? We offer a solution for 28 countries. Sales and marketing is our core business.

Learn more

Distribution

We manage, through our logistic partners with their regional warehouses, the distribution to our region (28 countries). They have the capability to handle the most demanding of specialized product order management, storage, handling and distribution requirements.

Learn more

Early Market Research

You know that market research is critical. It provides customer insights, competitive intelligence, behavioural tendencies, and product positioning. And market research increasingly is becoming an important component for linking R&D and marketing teams.

Learn more

Market Access

Achieving reimbursement and getting the right price are the 2 most important drivers for a successful launch of an innovative pharmaceuticals in our part of Europe. Health Authorities in any European country decide individually based on their local regulations, policies, framework, social values and available health care budget.

Learn more

Market Authorisation

Unlike other regions, in the EU a number of options is available to obtain a marketing authorisation. Centralised at the European Medicines Agency in Amsterdam or decentralised with the individual competent authorities of the member states, each marketing authorisation application procedure has its pros and cons. In the case of Switzerland, it has its own regulatory authority, Swissmedic, and processes.

Learn more

Pharmacovigilance

Pharmacovigilance is the science and activities relating to the detection, assessment, understanding and prevention of adverse effects or any other medicine-related problem.

Learn more

How about bringing your pharmaceuticals to 200 million Europeans? We are specialized in the Benelux, the Nordics and the CEE region as well.